IDEXX Laboratories revenue and financials
In the fiscal year ended December 2025, IDEXX Laboratories reported revenue of $4.3B (+10.42% year over year). Net income was $1.06B, a net margin of 24.6%.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +10.42%
- 2025 vs 2024
- Net income growth
- +19.33%
- 2025 vs 2024
- Net margin
- 24.6%
- 2024: 22.8%
How IDEXX Laboratories is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 9.7% a year on average over the last 5 years
Compound annual growth rate: from $2.71B in 2020 to $4.3B in 2025.
Revenue has grown for 9 fiscal years in a row
Each fiscal year compared with the one before, up to 2025.
Operating margin rose from 26.7% to 31.6%
Operating income over revenue, 2022 → 2025: 4.9 percentage points.
Profits turn into cash: free cash flow equal to 94% of net income
Totals for fiscal years 2023–2025: free cash flow $2.64B, net income $2.79B.
Shares outstanding down 6.6% in 5 years
Average diluted shares, 2020 → 2025: with fewer shares, each one represents a larger stake in the company.
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4,304 | 3,898 | 3,661 | 3,367 | 3,215 | 2,707 | 2,407 | 2,213 | 1,969 | 1,775 |
| Cost of revenue | 1,644 | 1,519 | 1,471 | 1,363 | 1,326 | 1,136 | 1,041 | 972 | 872 | 800 |
| Gross profit | 2,660 | 2,379 | 2,190 | 2,004 | 1,889 | 1,571 | 1,366 | 1,242 | 1,097 | 975 |
| Selling, general and administrative | 1,048 | 969 | 902 | 851 | 796 | 735 | 669 | 632 | 575 | 522 |
| Research and development | 251 | 220 | 191 | 255 | 161 | 141 | 133 | 118 | 109 | 101 |
| Operating income | 1,360 | 1,128 | 1,097 | 899 | 932 | 695 | 553 | 491 | 413 | 350 |
| EBIT | 1,360 | 1,190 | 1,097 | 899 | 932 | 695 | 564 | 491 | 413 | 352 |
| EBITDA | 1,505 | 1,320 | 1,212 | 1,011 | 1,037 | 791 | 652 | 575 | 496 | 431 |
| Interest expense | 38.9 | 31.2 | 41.6 | 39.9 | 29.8 | 33.1 | 31.1 | 34.7 | 37.2 | 32.0 |
| Pre-tax income | 1,324 | 1,110 | 1,061 | 860 | 903 | 662 | 522 | 458 | 381 | 322 |
| Income tax | 265 | 222 | 216 | 181 | 158 | 79.9 | 94.4 | 80.7 | 118 | 99.8 |
| Net income | 1,059 | 888 | 845 | 679 | 745 | 582 | 428 | 377 | 263 | 222 |
| Net income to common shareholders | 1,059 | 888 | 845 | 679 | 745 | 582 | 428 | 377 | 263 | 222 |
| Basic EPS | 13.17 | 10.77 | 10.17 | 8.12 | 8.74 | 6.82 | 4.97 | 4.34 | 3.00 | 2.47 |
| Diluted EPS | 13.08 | 10.67 | 10.06 | 8.03 | 8.60 | 6.71 | 4.89 | 4.26 | 2.94 | 2.44 |
| Average shares (basic) | 80.4 | 82.5 | 83.1 | 83.6 | 85.2 | 85.3 | 86.1 | 86.9 | 87.8 | 89.7 |
| Average shares (diluted) | 81.0 | 83.2 | 84.0 | 84.6 | 86.6 | 86.7 | 87.5 | 88.5 | 89.6 | 90.9 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1,214 | 1,217 | 1,141 | 1,091 | 1,105 | 1,109 | 998 | 954 | 976 | 1,004 | 964 | 902 |
| Cost of revenue | 450 | 437 | 418 | 432 | 422 | 415 | 375 | 384 | 380 | 384 | 371 | 375 |
| Gross profit | 764 | 779 | 723 | 658 | 683 | 695 | 623 | 571 | 596 | 619 | 593 | 526 |
| Selling, general and administrative | 293 | 288 | 294 | 267 | 265 | 260 | 257 | 251 | 238 | 238 | 241 | 229 |
| Research and development | 68.8 | 65.4 | 65.8 | 66.8 | 63.4 | 61.9 | 59.1 | 57.7 | 54.0 | 55.5 | 52.6 | 51.8 |
| Operating income | 402 | 426 | 363 | 325 | 355 | 373 | 308 | 262 | 304 | 325 | 299 | 245 |
| EBIT | 402 | 426 | 363 | 325 | 355 | 373 | 308 | 262 | 304 | 325 | 299 | 245 |
| EBITDA | 443 | 467 | 400 | 363 | 391 | 409 | 342 | 295 | 338 | 357 | 329 | 275 |
| Interest expense | 7.5 | 10.2 | 7.7 | 9.2 | 10.7 | 11.3 | 7.7 | 7.5 | 7.7 | 8.1 | 7.9 | 9.3 |
| Pre-tax income | 399 | 417 | 355 | 307 | 345 | 362 | 310 | 256 | 299 | 259 | 295 | 240 |
| Income tax | 82.2 | 78.8 | 77.0 | 58.8 | 70.2 | 68.4 | 67.4 | 40.2 | 66.1 | 55.8 | 59.9 | 45.1 |
| Net income | 317 | 338 | 278 | 248 | 275 | 294 | 243 | 216 | 233 | 203 | 236 | 195 |
| Net income to common shareholders | 317 | 338 | 278 | 248 | 275 | 294 | 243 | 216 | 233 | 203 | 236 | 195 |
| Basic EPS | 4.02 | 4.29 | 3.50 | 3.11 | 3.43 | 3.66 | 2.98 | 2.64 | 2.83 | 2.46 | 2.84 | 2.34 |
| Diluted EPS | 4.01 | 4.27 | 3.47 | 3.09 | 3.40 | 3.63 | 2.96 | 2.62 | 2.80 | 2.44 | 2.81 | 2.31 |
| Average shares (basic) | 78.8 | 79.0 | 79.6 | 79.9 | 80.1 | 80.4 | 81.3 | 81.8 | 82.3 | 82.6 | 83.1 | 83.1 |
| Average shares (diluted) | 79.0 | 79.3 | 80.2 | 80.5 | 80.7 | 81.0 | 81.9 | 82.5 | 83.1 | 83.4 | 84.0 | 83.9 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3,351 | 3,293 | 3,260 | 2,747 | 2,437 | 2,295 | 1,832 | 1,537 | 1,713 | 1,531 |
| Current assets | 1,414 | 1,400 | 1,495 | 1,101 | 956 | 1,063 | 680 | 654 | 972 | 846 |
| Cash and equivalents | 180 | 288 | 454 | 113 | 144 | 384 | 90.3 | 124 | 188 | 155 |
| Short-term investments | — | — | — | — | — | — | — | — | 284 | 237 |
| Receivables | 693 | 561 | 530 | 491 | 426 | 375 | 307 | 273 | 270 | 232 |
| Inventory | 378 | 382 | 380 | 368 | 269 | 210 | 195 | 173 | 164 | 158 |
| Net property, plant and equipment | 871 | 829 | 818 | 768 | 693 | 646 | 614 | 437 | 379 | 357 |
| Goodwill | 414 | 405 | 366 | 362 | 359 | 243 | 240 | 214 | 200 | 178 |
| Other intangible assets | 110 | 112 | 84.5 | 97.7 | 99.0 | 52.5 | 58.5 | 41.8 | 43.8 | 46.2 |
| Long-term investments | 31.8 | 31.0 | 30.3 | 30.3 | 5.3 | — | — | — | — | — |
| Current liabilities | 1,149 | 1,068 | 952 | 1,236 | 764 | 583 | 725 | 770 | 1,005 | 935 |
| Accounts payable | 110 | 114 | 111 | 110 | 116 | 74.6 | 72.2 | 69.5 | 67.0 | 60.1 |
| Long-term debt | 450 | 618 | 698 | 770 | 851 | 909 | 699 | 602 | 607 | 594 |
| Total debt | 579 | 737 | 817 | 891 | 958 | 1,003 | 1,070 | 1,000 | 1,261 | 1,204 |
| Total liabilities | 1,745 | 1,698 | 1,775 | 2,138 | 1,747 | 1,662 | 1,655 | 1,547 | 1,767 | 1,639 |
| Total equity (incl. minority) | 1,605 | 1,595 | 1,485 | 609 | 690 | 633 | 178 | -9.2 | -53.8 | -108 |
| Retained earnings | 6,392 | 5,332 | 4,445 | 3,600 | 2,920 | 2,176 | 1,596 | 1,168 | 804 | 540 |
| Minority interest | — | — | — | 0.0 | 0.0 | 0.7 | 0.4 | 0.3 | 0.3 | 0.1 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3,707 | 3,442 | 3,385 | 3,351 | 3,387 | 3,331 | 3,214 | 3,293 | 3,351 | 3,415 | 3,354 | 3,260 |
| Current assets | 1,500 | 1,509 | 1,454 | 1,414 | 1,477 | 1,362 | 1,318 | 1,400 | 1,434 | 1,529 | 1,502 | 1,495 |
| Cash and equivalents | 198 | 197 | 201 | 180 | 208 | 165 | 164 | 288 | 309 | 402 | 397 | 454 |
| Receivables | 721 | 742 | 697 | 693 | 715 | 663 | 604 | 561 | 587 | 608 | 578 | 530 |
| Inventory | 391 | 392 | 382 | 378 | 392 | 393 | 396 | 382 | 390 | 380 | 391 | 380 |
| Net property, plant and equipment | 852 | 856 | 862 | 871 | 868 | 869 | 834 | 829 | 839 | 828 | 829 | 818 |
| Goodwill | 641 | 411 | 412 | 414 | 414 | 414 | 407 | 405 | 412 | 408 | 409 | 366 |
| Other intangible assets | 118 | 98.2 | 105 | 110 | 115 | 104 | 107 | 112 | 107 | 111 | 115 | 84.5 |
| Long-term investments | 29.0 | 28.8 | 27.6 | 31.8 | 31.8 | 31.0 | 31.0 | 31.0 | 30.0 | 30.0 | 30.0 | 30.3 |
| Current liabilities | 1,264 | 1,288 | 1,300 | 1,149 | 1,252 | 1,224 | 1,136 | 1,068 | 1,009 | 1,117 | 957 | 952 |
| Accounts payable | 154 | 129 | 130 | 110 | 122 | 117 | 120 | 114 | 111 | 117 | 117 | 111 |
| Long-term debt | 300 | 300 | 300 | 375 | 375 | 450 | 450 | 450 | 525 | 525 | 621 | 623 |
| Total debt | 973 | 577 | 575 | 579 | 658 | 658 | 740 | 737 | 748 | 818 | 819 | — |
| Total liabilities | 1,838 | 1,830 | 1,829 | 1,745 | 1,826 | 1,872 | 1,766 | 1,698 | 1,733 | 1,835 | 1,785 | 1,775 |
| Total equity (incl. minority) | 1,869 | 1,613 | 1,556 | 1,605 | 1,561 | 1,459 | 1,448 | 1,595 | 1,618 | 1,580 | 1,569 | 1,485 |
| Retained earnings | 7,326 | 7,009 | 6,670 | 6,392 | 6,144 | 5,869 | 5,575 | 5,332 | 5,116 | 4,883 | 4,680 | 4,445 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1,182 | 929 | 907 | 543 | 756 | 648 | 459 | 400 | 373 | 339 |
| Depreciation and amortization | 145 | 130 | 115 | 112 | 105 | 96.0 | 88.0 | 83.2 | 83.1 | 78.2 |
| Capital expenditure | -125 | -121 | -134 | -149 | -120 | -107 | -155 | -116 | -74.4 | -64.8 |
| Investing cash flow | -136 | -207 | -125 | -195 | -293 | -109 | -206 | 139 | -139 | -90.8 |
| Financing cash flow | -1,165 | -878 | -442 | -371 | -697 | -248 | -286 | -598 | -208 | -222 |
| Share repurchases | -1,217 | -837 | -71.9 | -820 | -747 | -183 | -302 | -369 | -283 | -304 |
| Debt issued | 398 | 0.0 | 0.0 | 506 | 73.5 | 200 | 100 | — | 44.0 | 38.0 |
| Debt repaid | -428 | -75.0 | -404 | -75.0 | -50.0 | -290 | -110 | -256 | — | — |
| Effect of exchange rates | 11.2 | -9.5 | 2.1 | -8.6 | -4.6 | 3.3 | -0.7 | -4.8 | 6.2 | -0.1 |
| Net change in cash | -108 | -166 | 341 | -31.9 | -239 | 294 | -33.5 | -63.9 | 32.8 | 25.9 |
| Free cash flow | 1,057 | 808 | 773 | 394 | 636 | — | — | — | — | — |
| Levered free cash flow | 791 | 735 | 694 | 328 | 534 | 437 | 296 | 262 | 245 | 299 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 450 | 347 | 266 | 356 | 402 | 186 | 238 | 262 | 220 | 248 | 199 | 250 |
| Depreciation and amortization | 40.6 | 41.1 | 37.7 | 38.7 | 36.6 | 35.8 | 34.1 | 33.7 | 34.1 | 32.2 | 29.9 | 29.7 |
| Capital expenditure | -28.9 | -24.6 | -32.0 | -29.4 | -31.1 | -34.1 | -30.0 | -29.3 | -28.1 | -33.3 | -30.3 | -32.6 |
| Investing cash flow | -248 | -25.5 | -33.5 | -28.1 | -44.9 | -33.6 | -29.6 | -39.8 | -27.4 | -32.9 | -107 | -30.4 |
| Financing cash flow | -201 | -325 | -211 | -356 | -313 | -166 | -330 | -233 | -291 | -210 | -144 | -102 |
| Share repurchases | -112 | -347 | -362 | -238 | -240 | -339 | -407 | -246 | -221 | -216 | -165 | -36.9 |
| Debt issued | -45.0 | -11.0 | 132 | 193 | -124 | 260 | 69.5 | — | — | — | — | — |
| Debt repaid | -75.0 | — | — | -325 | 0.0 | -103 | — | 0.0 | -75.0 | — | — | -75.0 |
| Effect of exchange rates | -0.2 | -0.1 | -0.8 | -0.0 | -0.6 | 14.1 | -2.3 | -9.8 | 5.3 | -1.0 | -4.1 | 4.7 |
| Net change in cash | 0.6 | -3.6 | 20.5 | -28.1 | 43.6 | 0.6 | -124 | -20.4 | -93.0 | 4.2 | -56.5 | 122 |
| Free cash flow | 421 | 323 | 234 | 326 | 371 | 152 | 208 | 233 | 192 | 215 | 168 | 217 |
| Levered free cash flow | 381 | 230 | 166 | 286 | 227 | 119 | 159 | 171 | 172 | 254 | 139 | 228 |
Financial statements of similar companies
Companies in the group: same industry, similar size
